Genetic-induced Variations in the GAD65 T-cell Repertoire Governs Efficacy of Anti-CD3/GAD65 Combination Therapy in New-onset Type 1 Diabetes
Open Access
- 1 February 2010
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 18 (2) , 307-316
- https://doi.org/10.1038/mt.2009.197
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Gene gun-mediated DNA vaccination enhances antigen-specific immunotherapy at a late preclinical stage of type 1 diabetes in nonobese diabetic miceClinical Immunology, 2008
- GAD Treatment and Insulin Secretion in Recent-Onset Type 1 DiabetesNew England Journal of Medicine, 2008
- Impact of Diabetes Susceptibility Loci on Progression From Pre-Diabetes to Diabetes in At-Risk Individuals of the Diabetes Prevention Trial–Type 1 (DPT-1)Diabetes, 2008
- Defining the Role of the MHC in Autoimmunity: A Review and Pooled AnalysisPLoS Genetics, 2008
- Innocuous IFNγ induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 productionThe Journal of Experimental Medicine, 2008
- Moving towards efficient therapies in type 1 diabetes: To combine or not to combine?Autoimmunity Reviews, 2007
- Minimal Impact of a De Novo–Expressed β-Cell Autoantigen on Spontaneous Diabetes Development in NOD MiceDiabetes, 2007
- Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulationThe Journal of Experimental Medicine, 2007
- Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing TregsJournal of Clinical Investigation, 2006
- Direct access to CD4+ T cells specific for defined antigens according to CD154 expressionNature Medicine, 2005